Kay Yeung

Title(s)Associate Clinical Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
ORCID ORCID Icon0000-0002-0013-7002 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    New York University, New York, NYM.D., Ph.D.06/2012

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The Hallmarks of Predictive Oncology. Cancer Discov. 2025 Feb 07; 15(2):271-285. Singhal A, Zhao X, Wall P, So E, Calderini G, Partin A, Koussa N, Vasanthakumari P, Narykov O, Zhu Y, Jones SE, Abbas-Aghababazadeh F, Kadambat Nair S, Bélisle-Pipon JC, Jayaram A, Parker BA, Yeung KT, Griffiths JI, Weil R, Nath A, Haibe-Kains B, Ideker T. PMID: 39760657.
      View in: PubMed   Mentions:    Fields:    
    2. Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nat Med. 2024 Dec; 30(12):3737-3747. Shatsky RA, Trivedi MS, Yau C, Nanda R, Rugo HS, Davidian M, Tsiatis B, Wallace AM, Chien AJ, Stringer-Reasor E, Boughey JC, Omene C, Rozenblit M, Kalinsky K, Elias AD, Vaklavas C, Beckwith H, Williams N, Arora M, Nangia C, Roussos Torres ET, Thomas B, Albain KS, Clark AS, Falkson C, Hershman DL, Isaacs C, Thomas A, Tseng J, Sanford A, Yeung K, Boles S, Chen YY, Huppert L, Jahan N, Parker C, Giridhar K, Howard FM, Blackwood MM, Sanft T, Li W, Onishi N, Asare AL, Beineke P, Norwood P, Brown-Swigart L, Hirst GL, Matthews JB, Moore B, Symmans WF, Price E, Heditsian D, LeStage B, Perlmutter J, Pohlmann P, DeMichele A, Yee D, van 't Veer LJ, Hylton NM, Esserman LJ. PMID: 39277672.
      View in: PubMed   Mentions:    Fields:    Translation:CTClinical Trials
    3. Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nat Med. 2024 Dec; 30(12):3728-3736. Khoury K, Meisel JL, Yau C, Rugo HS, Nanda R, Davidian M, Tsiatis B, Chien AJ, Wallace AM, Arora M, Rozenblit M, Hershman DL, Zimmer A, Clark AS, Beckwith H, Elias AD, Stringer-Reasor E, Boughey JC, Nangia C, Vaklavas C, Omene C, Albain KS, Kalinsky KM, Isaacs C, Tseng J, Roussos Torres ET, Thomas B, Thomas A, Sanford A, Balassanian R, Ewing C, Yeung K, Sauder C, Sanft T, Pusztai L, Trivedi MS, Outhaythip A, Li W, Onishi N, Asare AL, Beineke P, Norwood P, Brown-Swigart L, Hirst GL, Matthews JB, Moore B, Fraser Symmans W, Price E, Beedle C, Perlmutter J, Pohlmann P, Shatsky RA, DeMichele A, Yee D, van 't Veer LJ, Hylton NM, Esserman LJ. PMID: 39277671.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    4. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 07; 22(5):331-357. Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, Allison KH, Anderson B, Bailey J, Burstein HJ, Chen N, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Jankowitz RC, Javid SH, Krishnamurthy J, Leitch AM, Lyons J, McCloskey S, McShane M, Mortimer J, Patel SA, Rosenberger LH, Rugo HS, Santa-Maria C, Schneider BP, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Wei M, Wisinski KB, Yeung KT, Young JS, Schonfeld R, Kumar R. PMID: 39019058.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    5. LHPP expression in triple-negative breast cancer promotes tumor growth and metastasis by modulating the tumor microenvironment. bioRxiv. 2024 Apr 23. Reina J, Vallmajo-Martin Q, Ning J, Michi AN, Yeung K, Wahl GM, Hunter T. PMID: 38712081; PMCID: PMC11071390.
      View in: PubMed   Mentions:
    6. A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitors. Nat Cancer. 2024 Jul; 5(7):996-1009. Park S, Silva E, Singhal A, Kelly MR, Licon K, Panagiotou I, Fogg C, Fong S, Lee JJY, Zhao X, Bachelder R, Parker BA, Yeung KT, Ideker T. PMID: 38443662; PMCID: PMC11286358.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    7. Growth signaling autonomy in circulating tumor cells aids metastatic seeding. PNAS Nexus. 2024 Feb; 3(2):pgae014. Sinha S, Farfel A, Luker KE, Parker BA, Yeung KT, Luker GD, Ghosh P. PMID: 38312224; PMCID: PMC10833458.
      View in: PubMed   Mentions: 3  
    8. NCCN Guidelines® Insights: Breast Cancer, Version 4.2023. J Natl Compr Canc Netw. 2023 06; 21(6):594-608. Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, Allison KH, Anderson B, Burstein HJ, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, Hurvitz SA, Jankowitz RC, Javid SH, Krishnamurthy J, Leitch AM, Lyons J, Mortimer J, Patel SA, Pierce LJ, Rosenberger LH, Rugo HS, Schneider B, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Wei M, Wisinski KB, Young JS, Yeung K, Dwyer MA, Kumar R. PMID: 37308117.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    9. Identification of CD105+ Extracellular Vesicles as a Candidate Biomarker for Metastatic Breast Cancer. J Surg Res. 2021 12; 268:168-173. Douglas SR, Yeung KT, Yang J, Blair SL, Cohen O, Eliceiri BP. PMID: 34314883; PMCID: PMC8805608.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    10. Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer. Sci Rep. 2018 03 05; 8(1):4013. Nakazawa Y, Taniyama Y, Sanada F, Morishita R, Nakamori S, Morimoto K, Yeung KT, Yang J. PMID: 29507310; PMCID: PMC5838092.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimals
    11. Circulating Tumor DNA for Mutation Detection and Identification of Mechanisms of Resistance in Non-Small Cell Lung Cancer. Mol Diagn Ther. 2017 08; 21(4):375-384. Yeung KT, More S, Woodward B, Velculescu V, Husain H. PMID: 28337711.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    12. Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol. 2017 01; 11(1):28-39. Yeung KT, Yang J. PMID: 28085222; PMCID: PMC5242415.
      View in: PubMed   Mentions: 348     Fields:    Translation:HumansAnimalsCells
    13. Lenvatinib in Advanced, Radioactive Iodine-Refractory, Differentiated Thyroid Carcinoma. Clin Cancer Res. 2015 Dec 15; 21(24):5420-6. Yeung KT, Cohen EE. PMID: 26487760.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    14. Fas Activated Serine-Threonine Kinase Domains 2 (FASTKD2) mediates apoptosis of breast and prostate cancer cells through its novel FAST2 domain. BMC Cancer. 2014 Nov 20; 14:852. Das S, Yeung KT, Mahajan MA, Samuels HH. PMID: 25409762; PMCID: PMC4256816.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    15. A novel transcription complex that selectively modulates apoptosis of breast cancer cells through regulation of FASTKD2. Mol Cell Biol. 2011 Jun; 31(11):2287-98. Yeung KT, Das S, Zhang J, Lomniczi A, Ojeda SR, Xu CF, Neubert TA, Samuels HH. PMID: 21444724; PMCID: PMC3133243.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    16. Identification of a novel pathway that selectively modulates apoptosis of breast cancer cells. Cancer Res. 2009 Feb 15; 69(4):1375-82. Tinnikov AA, Yeung KT, Das S, Samuels HH. PMID: 19190336; PMCID: PMC4264605.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    17. DNA-looping by RXR tetramers permits transcriptional regulation "at a distance". J Mol Biol. 2004 Oct 15; 343(2):327-38. Yasmin R, Yeung KT, Chung RH, Gaczynska ME, Osmulski PA, Noy N. PMID: 15451664.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    Kay's Networks
    Concepts (109)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (24)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-12-gbedcc43d on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California